Ann: Race global agreement with City of Hope to access FTO IP, page-49

I've read the release and all the posts and am still confused (accept that I am probably the problem :-( )

- Even if partnering with CoH is great for RAC, I don't understand how they can create IP from our product that we then have to licence from them. If I make an ice block out of Coca Cola, it seems like asking Coke to pay me a royalty for every ice block they sell. Someone please explain to me like I'm a 5 year old why we have to pay someone a royalty for research they did using our product.
- What is the product we're paying a royalty for? We're agreeing to be them low single digit % (say 5%) of every product sold in the future in exchange for what - research they did on our product? Again, like I'm 5, how is it worth 5% of the business?
- \If there's ongoing trials, publications, licencing, IP, etc over the next 4-6 years with the aim of sale/commercialisation, are CoH paying for it? Are we now going to be paying CoH for research they were doing anyway and are now going to be funded by us AND we pay them 5% royalty for sale/products that come out of it? Feels like double dipping.

From RAC's other recent release:
- Cancellation of development of 110 formulation central venous and focus total development on 220 IV formulation. Does this mean all the research to date on efficacy of 110 is wasted and have to start again on 220? Wasn't all of CoH's research on 110? This would be backed by the final 2 patients in the Israeli study being recruited to 220 formulation. Isn't it now invalid?
- Cancellation on research on efficacy of heart protection in conjunction with other cancer treatments, especially breast cancer RAC008, yet the ongoing heart protection studies to be released in Q3. This was touted as a "bonus" value add and big pharma interest attractor. Why cancel an existing test whilst continuing studies?
- The saving of $3m from the cancellation of above study to focus on 220. Are RAC so cash concerned that they are having to cancel studies to have cash for new studies?

Interested in your, and other interested RAC holders, thoughts.